Nonalcoholic fatty liver disease. Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: Taking L-carnitine supplement at a dose of one gram every 12 hours for 3 months. Intervention 2: Control group: Taking placebo at a dose of one gram every 12 hours
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: AST, ALT levels above the normal range Sonographic findings consistent with fatty liver No history of viral hepatitis or conditions such as hemochromatosis, Wilson’s disease, autoimmune hepatitis, alpha-1 antitrypsin deficiency or chronic liver disease
Exclusion criteria
Exclusion criteria: Significant alcohol consumption (more than 10 grams per day for women and more than 20 grams per day for men) Pregnant or breastfeeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decreased level of liver enzymes. Timepoint: Measurement of liver enzymes at the beginning of the study (before the start of the intervention) and 3 months after L-carnitine supplementation. Method of measurement: Check the level of liver enzymes in the serum by the laboratory.;Reducing the amount of liver fat. Timepoint: Measurement of liver enzymes at the beginning of the study (before the start of the intervention) and 3 months after L-carnitine supplementation. Method of measurement: Tansabdominal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Nezhadisalami
Ahvaz University of Medical Sciences
Outcome results
None listed